In silico prediction and experimental validation of natural antisense transcripts in two cancer-associated regions of human chromosome 6

International Journal of Oncology

Volumn 34, Issue 4, 2009, Pages 1099-1108

  Monti, Laura ^a   Cinquetti, Raffaella ^a   Guffanti, Alessandro ^b   Nicassio, Francesco ^c   Cremona, Mattia ^d   Lavorgna, Giovanni ^e   Bianchi, Fabrizio ^c   Vignati, Francesca ^a   Cittaro, Davide ^c   Taramelli, Roberto ^a   Acquati, Francesco ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b INSTITUTE OF BIOMEDICAL TECHNOLOGIES   (Italy)

^c FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^d NATIONAL CANCER INSTITUTE   (Italy)

^e SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Antisense RNA; Chromosome 6; Transcriptional regulation; Tumor suppressor genes

Indexed keywords

COMPLEMENTARY RNA; S6 KINASE;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER GENETICS; CHROMOSOME 6Q; COMPUTER MODEL; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MALIGNANT NEOPLASTIC DISEASE; NUCLEOTIDE SEQUENCE; PREDICTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; VALIDATION STUDY;

CHROMOSOMES, HUMAN, PAIR 6; COMPUTATIONAL BIOLOGY; GENES, TUMOR SUPPRESSOR; GENOME, HUMAN; HUMANS; INTRONS; MODELS, BIOLOGICAL; MODELS, GENETIC; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OLIGONUCLEOTIDES, ANTISENSE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; RNA, ANTISENSE;

EID: 67649451972     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000237     Document Type: Article

References (44)

1. Zhang Y, Matthiesen P, Harder S, et al: A 3-cM commonly deleted region in 6q21 in leukemias and lymphomas delineated by fluorescence in situ hybridization. Genes Chromosomes Cancer 27: 52-58, 2000.
2. Tibiletti MG, Trubia M, Ponti E, et al: Physical map of the D6S149-D6S193 region on chromosome 6q27 and its involvement in benign surface epithelial ovarian tumours. Oncogene 16: 1639-1642, 1998.
3. Miele ME, Jewett MD, Goldberg SF, et al: A human melanoma metastasis-suppressor locus maps to 6q16.3-q23. Int J Cancer 86: 524-528, 2000.
4. Trent JM, Stanbridge EJ, McBride HL, et al: Tumorigenicity in human melanoma cell lines controlled by introduction of human chromosome 6. Science 247: 568-571, 1990.
5. Negrini M, Sabbioni S, Possati L, Rattan S, Corallini A, Barbanti-Brodano G and Croce CM: Suppression of tumorigenicity of breast cancer cells by microcell-mediated chromosome transfer: studies on chromosomes 6 and 11. Cancer Res 54: 1331-1336, 1994.
6. Theile M, Seitz S, Arnold W, et al: A defined chromosome 6q fragment (at D6S310) harbors a putative tumor suppressor gene for breast cancer. Oncogene 13: 677-685, 1996.
7. Pasqualucci L, Compagno M, Houldsworth J, et al: Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma. J Exp Med 203: 311-317, 2006.
8. Bignone PA, Lee KY, Liu Y, et al: RPS6KA2, a putative tumour suppressor gene at 6q27 in sporadic epithelial ovarian cancer. Oncogene 26: 683-700, 2007.
9. Acquati F, Morelli C, Cinquetti R, et al: Cloning and characterization of a senescence inducing and class II tumor suppressor gene in ovarian carcinoma at chromosome region 6q27. Oncogene 20: 980-988, 2001.
10. Steinemann D, Gesk S, Zhang Y, et al: Identification of candidate tumor suppressor genes in 6q27 by combined deletion mapping and electronic expression profiling in lymphoid neoplasms. Genes Chromosomes Cancer 37: 421-426, 2003.
11. Sinclair PB, Sorour A, Martineau M, et al: A fluorescence in situ hybridization map of 6q deletions in acute lymphocytic leukemia: identification and analysis of a candidate tumor suppressor gene. Cancer Res 64: 4089-4098, 2004.
12. Rutherford S, Yu Y, Rumpel CA, Frierson HF Jr and Moskaluk CA: Chromosome 6 deletion and candidate tumor suppressor genes in adenoid cystic carcinoma. Cancer Lett 236: 309-317, 2006.
13. Zhang L, Anglesio MS, O'Sullivan M, et al: The E3 ligase HACE1 is a critical chromosome 6q21 tumos suppressor involved in multiple cancers. Nat Med 13: 1060-1069, 2007.
14. Lavorgna G, Dahary D, Lehner B, Sorek R, Sanderson CM and Casari G: In search of antisense. Trends Biochem Sci 2: 88-94, 2004.
15. Lapidot M and Pilpel Y: Genome-wide natural antisense transcription: coupling its regulation to its different regulatory mechanisms. EMBO Rep 7: 1216-1222, 2006.
16. Shendure J and Church GM: Computational discovery of sense-antisense transcription in the human and mouse genomes. Genome Biol 3: 22, 2002.
17. Yelin R, Dahary D, Sorek R, et al: Widespread occurrence of antisense transcription in the human genome. Nat Biotechnol 21: 379-386, 2003.
18. Chen J, Sun M, Kent WJ, et al: Over 20% of human transcripts might form sense-antisense pairs. Nucleic Acids Res 32: 4812-4820, 2004.
19. Engstrom PG, Suzuki H, Ninomiya N, et al: Complex loci in human and mouse genomes. PLoS Genet 2, e47: 564-577, 2006.
20. Katayama S, Tomaru Y, Kasukawa T, et al: Antisense transcription in the mammalian transcriptome. Science 309: 1564-1566, 2005.
21. Schwab M: Amplification of oncogenes in human cancer cells. Bioessays 20: 473-479, 1998.
22. Laird PW: Cancer epigenetics. Hum Mol Genet 14: R65-R76, 2005.
23. Tufarelli C, Stanley JA, Garrick D, Sharpe JA, Ayyub H, Wood WG and Higgs DR: Transcription of antisense RNA leading to gene silencing and methylation as a novel cause of human genetic disease. Nat Genet 34: 157-165, 2003.
24. Yu W, Gius D, Onyango P, et al: Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA. Nature 451: 202-206, 2007.
25. Moorwood K, Charles AK, Salpekar A, Wallace JI, Brown KW and Malik K: Antisense WT1 transcription parallels sense mRNA and protein expression in fetal kidney and can elevate protein levels in vitro. J Pathol 185: 352-359, 1998.
26. Rossignol F, Vache C and Clottes E: Natural antisense transcripts of hypoxia-inducible factor 1alpha are detected in different normal and tumour human tissues. Gene 299: 135-140, 2002.
27. Corcoran MM, Hammarsund M, Zhu C, et al: DLEU2 encodes an antisense RNA for the putative bicistronic RFP2/LEU5 gene in humans and mouse. Genes Chromosomes Cancer 40: 285-297, 2004.
28. Lavorgna G, Sessa L, Guffanti A, Lassandro L and Casari G: AntiHunter: searching BLAST output for EST antisense transcripts. Bioinformatics 20: 583-585, 2004.
29. Vecchi M, Confalonieri S, Nuciforo P, et al: Breast cancer metastases are molecularly distinct from their primary tumors. Oncogene 27: 2148-2158, 2008.
30. Nicassio F, Bianchi F, Capra M, et al: A cancer-specific transcriptional signature in human neoplasia. J Clin Invest 115: 3015-3025, 2005.
31. Galante PA, Vidal DO, De Souza JE, Camargo AA and De Souza SJ: Sense-antisense pairs in mammals: functional and evolutionary considerations. Genome Biol 8: R40, 2007.
32. Thierry-Mieg D and Thierry-Mieg J: AceView: a comprehensive cDNA-supported gene and transcripts annotation. Genome Biol 7 (Suppl. 1): S12, 2006.
33. Chen J, Sun M, Hurst LD, Carmichael GG and Rowley JD: Genome-wide analysis of coordinate expression and evolution of human cis-encoded sense-antisense transcripts. Trends Genet 21: 326-329, 2005.
34. Dahary D, Elroy-Stein O and Sorek R: Naturally occurring antisense: transcriptional leakage or real overlap? Genome Res 15: 364-368, 2005.
35. Boguski MS and Jones AR: Neurogenomics: at the intersection of neurobiology and genome sciences. Nat Neurosci 7: 429-433, 2004.
36. Kiyosawa H, Mise N, Iwase S, Hayashizaki Y and Abe K: Disclosing hidden transcripts: mouse natural sense-antisense transcripts tend to be poly(A) negative and nuclear localized. Genome Res 4: 463-474, 2005.
37. Rougeulle C and Heard E: Antisense RNA in imprinting: spreading silence through Air. Trends Genet 18: 434-437, 2002.
38. Laird PW: Cancer epigenetics. Hum Mol Genet 14: R65-R76, 2005.
39. Duesberg P, Li R, Fabarius A and Hehlmann R: The chromosomal basis of cancer. Cell Oncol 27: 293-318, 2005.
40. Reis EM, Nakaya HI, Louro R, et al: Antisense intronic non-coding RNA levels correlate to the degree of tumor differentiation in prostate cancer. Oncogene 23: 6684-6692, 2004.
41. Finocchiaro G, Carro MS, Francois S, Parise P, Di Ninni V and Muller H: Localizing hotspots of antisense transcription. Nucleic Acids Res 35: 1488-1500, 2007.
42. Tomlinson IP, Lambros MBK and Roylance RR: Loss of heterozygosity analysis: practically and conceptually flawed? Genes Chromosomes Cancer 34: 349-353, 2002.
43. Li Y, Huang YL, He J, Wang W, Davies KE, Nose V and Xiao S: UTRN on chromosome 6q24 is mutated in multiple tumors. Oncogene 26: 6220-6228, 2007.
44. Reis EM, Louro R, Nakaya HI and Verjovski-Almeida S: As antisense RNA gets intronic. OMICS 9: 2-12, 2005.